| Item Type | Name |
|
Academic Article
|
Structural stability of disulfide mutants of basic pancreatic trypsin inhibitor: a molecular dynamics study.
|
|
Academic Article
|
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B.
|
|
Academic Article
|
The role of protein-solvent interactions in protein unfolding.
|
|
Academic Article
|
Accessibility and order of water sites in and around proteins: A crystallographic time-averaging study.
|
|
Academic Article
|
Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013.
|
|
Academic Article
|
Crystal structure of human thymidylate synthase: a structural mechanism for guiding substrates into the active site.
|
|
Academic Article
|
Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance.
|
|
Academic Article
|
The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication.
|
|
Academic Article
|
Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease.
|
|
Academic Article
|
Cooperative fluctuations of unliganded and substrate-bound HIV-1 protease: a structure-based analysis on a variety of conformations from crystallography and molecular dynamics simulations.
|
|
Academic Article
|
Time-averaging crystallographic refinement: possibilities and limitations using alpha-cyclodextrin as a test system.
|
|
Academic Article
|
Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor.
|
|
Academic Article
|
Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor.
|
|
Academic Article
|
Design of HIV-1 protease inhibitors active on multidrug-resistant virus.
|
|
Academic Article
|
PTEN enters the nucleus by diffusion.
|
|
Academic Article
|
Crystallization of human thymidylate synthase.
|
|
Academic Article
|
Co-evolution of nelfinavir-resistant HIV-1 protease and the p1-p6 substrate.
|
|
Academic Article
|
Substrate envelope and drug resistance: crystal structure of RO1 in complex with wild-type human immunodeficiency virus type 1 protease.
|
|
Academic Article
|
How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease.
|
|
Academic Article
|
Competition between Ski and CREB-binding protein for binding to Smad proteins in transforming growth factor-beta signaling.
|
|
Academic Article
|
Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease.
|
|
Academic Article
|
Design of mutation-resistant HIV protease inhibitors with the substrate envelope hypothesis.
|
|
Academic Article
|
Design and synthesis of HIV-1 protease inhibitors incorporating oxazolidinones as P2/P2' ligands in pseudosymmetric dipeptide isosteres.
|
|
Academic Article
|
Contribution of Ser386 and Ser396 to activation of interferon regulatory factor 3.
|
|
Academic Article
|
Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5.
|
|
Academic Article
|
Viral protease inhibitors.
|
|
Academic Article
|
Additivity in the analysis and design of HIV protease inhibitors.
|
|
Academic Article
|
Toward the design of mutation-resistant enzyme inhibitors: further evaluation of the substrate envelope hypothesis.
|
|
Academic Article
|
Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces.
|
|
Academic Article
|
Lack of synergy for inhibitors targeting a multi-drug-resistant HIV-1 protease.
|
|
Academic Article
|
Structure of a phage display-derived variant of human growth hormone complexed to two copies of the extracellular domain of its receptor: evidence for strong structural coupling between receptor binding sites.
|
|
Academic Article
|
The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways.
|
|
Academic Article
|
Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones.
|
|
Academic Article
|
Molecular mechanisms of viral and host cell substrate recognition by hepatitis C virus NS3/4A protease.
|
|
Academic Article
|
Dynamics of preferential substrate recognition in HIV-1 protease: redefining the substrate envelope.
|
|
Academic Article
|
The challenge of developing robust drugs to overcome resistance.
|
|
Academic Article
|
Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes.
|
|
Academic Article
|
Molecular Basis for Drug Resistance in HIV-1 Protease.
|
|
Academic Article
|
First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G.
|
|
Academic Article
|
Hydrophobic core flexibility modulates enzyme activity in HIV-1 protease.
|
|
Academic Article
|
Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease.
|
|
Academic Article
|
Design, synthesis, and biological and structural evaluations of novel HIV-1 protease inhibitors to combat drug resistance.
|
|
Academic Article
|
Extreme entropy-enthalpy compensation in a drug-resistant variant of HIV-1 protease.
|
|
Academic Article
|
Methylcytosine and normal cytosine deamination by the foreign DNA restriction enzyme APOBEC3A.
|
|
Academic Article
|
The molecular basis of drug resistance against hepatitis C virus NS3/4A protease inhibitors.
|
|
Academic Article
|
Point mutants of EHEC intimin that diminish Tir recognition and actin pedestal formation highlight a putative Tir binding pocket.
|
|
Academic Article
|
Nitric oxide-mediated inhibition of Hdm2-p53 binding.
|
|
Academic Article
|
Viability of a drug-resistant human immunodeficiency virus type 1 protease variant: structural insights for better antiviral therapy.
|
|
Academic Article
|
Cooperative effects of drug-resistance mutations in the flap region of HIV-1 protease.
|
|
Academic Article
|
Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments.
|
|
Academic Article
|
Structure-based prediction of potential binding and nonbinding peptides to HIV-1 protease.
|
|
Academic Article
|
Covariation of amino acid positions in HIV-1 protease.
|
|
Academic Article
|
Promise of advances in simulation methods for protein crystallography: implicit solvent models, time-averaging refinement, and quantum mechanical modeling.
|
|
Academic Article
|
Simultaneous refinement of the structure of BPTI against NMR data measured in solution and X-ray diffraction data measured in single crystals.
|
|
Academic Article
|
Accounting for molecular mobility in structure determination based on nuclear magnetic resonance spectroscopic and X-ray diffraction data.
|
|
Academic Article
|
Exploring the role of the solvent in the denaturation of a protein: a molecular dynamics study of the DNA binding domain of the 434 repressor.
|
|
Academic Article
|
Expression, purification, and characterization of thymidylate synthase from Lactococcus lactis.
|
|
Academic Article
|
Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow.
|
|
Academic Article
|
Inclusion of solvation free energy with molecular mechanics energy: alanyl dipeptide as a test case.
|
|
Academic Article
|
Combating susceptibility to drug resistance: lessons from HIV-1 protease.
|
|
Academic Article
|
Structural basis for coevolution of a human immunodeficiency virus type 1 nucleocapsid-p1 cleavage site with a V82A drug-resistant mutation in viral protease.
|
|
Academic Article
|
Association of a novel human immunodeficiency virus type 1 protease substrate cleft mutation, L23I, with protease inhibitor therapy and in vitro drug resistance.
|
|
Academic Article
|
Mechanism of substrate recognition by drug-resistant human immunodeficiency virus type 1 protease variants revealed by a novel structural intermediate.
|
|
Academic Article
|
Substrate specificity in HIV-1 protease by a biased sequence search method.
|
|
Academic Article
|
Role of invariant Thr80 in human immunodeficiency virus type 1 protease structure, function, and viral infectivity.
|
|
Academic Article
|
RecA dimers serve as a functional unit for assembly of active nucleoprotein filaments.
|
|
Academic Article
|
Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands.
|
|
Academic Article
|
N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure.
|
|
Academic Article
|
Hydrophobic sliding: a possible mechanism for drug resistance in human immunodeficiency virus type 1 protease.
|
|
Academic Article
|
Prediction of homologous protein structures based on conformational searches and energetics.
|
|
Academic Article
|
Crystal structure of lysine sulfonamide inhibitor reveals the displacement of the conserved flap water molecule in human immunodeficiency virus type 1 protease.
|
|
Academic Article
|
Mass spectrometry analysis of HIV-1 Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity.
|
|
Academic Article
|
Computational design and experimental study of tighter binding peptides to an inactivated mutant of HIV-1 protease.
|
|
Academic Article
|
HIV-1 protease inhibitors from inverse design in the substrate envelope exhibit subnanomolar binding to drug-resistant variants.
|
|
Academic Article
|
Structural analysis of human immunodeficiency virus type 1 CRF01_AE protease in complex with the substrate p1-p6.
|
|
Academic Article
|
Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
|
|
Academic Article
|
New approaches to HIV protease inhibitor drug design II: testing the substrate envelope hypothesis to avoid drug resistance and discover robust inhibitors.
|
|
Academic Article
|
Human immunodeficiency virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistance.
|
|
Academic Article
|
Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance.
|
|
Academic Article
|
Rationale for more diverse inhibitors in competition with substrates in HIV-1 protease.
|
|
Academic Article
|
Investigations of peptide hydration using NMR and molecular dynamics simulations: A study of effects of water on the conformation and dynamics of antamanide.
|
|
Academic Article
|
Therapeutic targeting of C-terminal binding protein in human cancer.
|
|
Academic Article
|
Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding.
|
|
Academic Article
|
Three residues in HIV-1 matrix contribute to protease inhibitor susceptibility and replication capacity.
|
|
Academic Article
|
TMC310911, a novel human immunodeficiency virus type 1 protease inhibitor, shows in vitro an improved resistance profile and higher genetic barrier to resistance compared with current protease inhibitors.
|
|
Academic Article
|
Decomposing the energetic impact of drug-resistant mutations: the example of HIV-1 protease-DRV binding.
|
|
Academic Article
|
Quantitative comparison of errors in 15N transverse relaxation rates measured using various CPMG phasing schemes.
|
|
Academic Article
|
Structural, kinetic, and thermodynamic studies of specificity designed HIV-1 protease.
|
|
Academic Article
|
Mass spectrometry tools for analysis of intermolecular interactions.
|
|
Academic Article
|
Structural insights into neuronal K+ channel-calmodulin complexes.
|
|
Academic Article
|
Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance.
|
|
Academic Article
|
Structural and thermodynamic basis of amprenavir/darunavir and atazanavir resistance in HIV-1 protease with mutations at residue 50.
|
|
Academic Article
|
Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain.
|
|
Academic Article
|
Interview with Celia Schiffer.
|
|
Academic Article
|
Evolution of the influenza A virus genome during development of oseltamivir resistance in vitro.
|
|
Academic Article
|
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia.
|
|
Academic Article
|
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583.
|
|
Concept
|
Tandem Mass Spectrometry
|
|
Concept
|
Blotting, Southern
|
|
Concept
|
Drug Stability
|
|
Concept
|
Sperm Motility
|
|
Concept
|
Drug Administration Schedule
|
|
Concept
|
Sequence Analysis, DNA
|
|
Concept
|
Receptors, Somatotropin
|
|
Concept
|
Survival Rate
|
|
Concept
|
Data Interpretation, Statistical
|
|
Concept
|
Mass Spectrometry
|
|
Concept
|
Software
|
|
Concept
|
Sequence Analysis, RNA
|
|
Concept
|
Tumor Suppressor Protein p53
|
|
Concept
|
Magnetic Resonance Spectroscopy
|
|
Concept
|
Influenza A Virus, H1N2 Subtype
|
|
Concept
|
Genes, Tumor Suppressor
|
|
Concept
|
Stereoisomerism
|
|
Concept
|
Seminal Plasma Proteins
|
|
Concept
|
Oncogenes
|
|
Concept
|
Epistasis, Genetic
|
|
Concept
|
Mutagenesis, Site-Directed
|
|
Concept
|
Genome, Bacterial
|
|
Concept
|
Quantitative Structure-Activity Relationship
|
|
Concept
|
Influenza A Virus, H1N1 Subtype
|
|
Concept
|
Amyotrophic Lateral Sclerosis
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
Information Storage and Retrieval
|
|
Concept
|
Cell Survival
|
|
Concept
|
Receptors, Cell Surface
|
|
Concept
|
Selection, Genetic
|
|
Concept
|
Genes, Viral
|
|
Concept
|
Amino Acid Substitution
|
|
Concept
|
Chi-Square Distribution
|
|
Concept
|
Syndrome
|
|
Concept
|
Computer Simulation
|
|
Concept
|
Immunoglobulin A, Secretory
|
|
Concept
|
Genetic Code
|
|
Concept
|
Amino Acid Sequence
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
Drug Delivery Systems
|
|
Concept
|
Two-Hybrid System Techniques
|
|
Concept
|
Saccharomyces cerevisiae
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Myelodysplastic Syndromes
|
|
Concept
|
Reference Standards
|
|
Concept
|
Nervous System Diseases
|
|
Concept
|
Smad Proteins
|
|
Concept
|
Small Molecule Libraries
|
|
Concept
|
Intracellular Signaling Peptides and Proteins
|
|
Concept
|
Serine Proteinase Inhibitors
|
|
Concept
|
Spectrometry, Mass, Electrospray Ionization
|
|
Concept
|
Spermatozoa
|
|
Concept
|
Solvents
|
|
Concept
|
Static Electricity
|
|
Concept
|
Molecular Structure
|
|
Concept
|
Conserved Sequence
|
|
Concept
|
Genes, ras
|
|
Concept
|
Insulin-Secreting Cells
|
|
Concept
|
Models, Statistical
|
|
Concept
|
Influenza A Virus, H3N2 Subtype
|
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
|
Concept
|
Surface-Active Agents
|
|
Concept
|
Drug Synergism
|
|
Concept
|
Signal Transduction
|
|
Concept
|
Nucleic Acid Conformation
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
Protein Structure, Secondary
|
|
Concept
|
Thymidylate Synthase
|
|
Concept
|
Hematopoietic Stem Cells
|
|
Concept
|
High-Throughput Screening Assays
|
|
Concept
|
Protein Structure, Tertiary
|
|
Concept
|
Adaptor Proteins, Signal Transducing
|
|
Concept
|
Smoking
|
|
Concept
|
Sulfonic Acids
|
|
Concept
|
Viral Structural Proteins
|
|
Concept
|
Catalytic Domain
|
|
Concept
|
Antigens, Surface
|
|
Concept
|
Core Binding Factor beta Subunit
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Sex Factors
|
|
Concept
|
Vaccines, Synthetic
|
|
Concept
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
|
|
Concept
|
Enzyme Stability
|
|
Concept
|
Skin Diseases, Infectious
|
|
Concept
|
Survivors
|
|
Concept
|
Neurotoxicity Syndromes
|
|
Concept
|
Sequence Alignment
|
|
Concept
|
Synchrotrons
|
|
Concept
|
Serine Proteases
|
|
Concept
|
Protein Structure, Quaternary
|
|
Concept
|
Structural Homology, Protein
|
|
Concept
|
Binding Sites
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Microbial Sensitivity Tests
|
|
Concept
|
Induced Pluripotent Stem Cells
|
|
Concept
|
Calcium Signaling
|
|
Concept
|
Neoplasm Staging
|
|
Concept
|
Antibody Specificity
|
|
Concept
|
Macromolecular Substances
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Stochastic Processes
|
|
Concept
|
Socioeconomic Factors
|
|
Concept
|
Sequence Homology, Amino Acid
|
|
Concept
|
Solutions
|
|
Concept
|
Stress, Psychological
|
|
Concept
|
Sequence Homology, Nucleic Acid
|
|
Concept
|
Substrate Specificity
|
|
Concept
|
Genome-Wide Association Study
|
|
Concept
|
Surveys and Questionnaires
|
|
Concept
|
Serine Endopeptidases
|
|
Concept
|
Allosteric Site
|
|
Concept
|
Rats, Sprague-Dawley
|
|
Concept
|
Swine
|
|
Concept
|
United States
|
|
Concept
|
Serine
|
|
Concept
|
Sulfonamides
|
|
Concept
|
Anemia, Sickle Cell
|
|
Concept
|
Structure-Activity Relationship
|
|
Concept
|
Staurosporine
|
|
Concept
|
Base Sequence
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Genome, Viral
|
|
Concept
|
DNA, Single-Stranded
|
|
Concept
|
Molecular Sequence Data
|
|
Concept
|
Surface Properties
|
|
Academic Article
|
Influenza virus drug resistance: a time-sampled population genetics perspective.
|
|
Academic Article
|
Evaluating the role of macrocycles in the susceptibility of hepatitis C virus NS3/4A protease inhibitors to drug resistance.
|
|
Academic Article
|
A sensitive assay using a native protein substrate for screening HIV-1 maturation inhibitors targeting the protease cleavage site between the matrix and capsid.
|
|
Academic Article
|
Testing the substrate-envelope hypothesis with designed pairs of compounds.
|
|
Academic Article
|
Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance.
|
|
Academic Article
|
The interdomain interface in bifunctional enzyme protein 3/4A (NS3/4A) regulates protease and helicase activities.
|
|
Academic Article
|
Crystal structures of human CtBP in complex with substrate MTOB reveal active site features useful for inhibitor design.
|
|
Academic Article
|
HIV-1 protease-substrate coevolution in nelfinavir resistance.
|
|
Academic Article
|
Differential Flap Dynamics in Wild-type and a Drug Resistant Variant of HIV-1 Protease Revealed by Molecular Dynamics and NMR Relaxation.
|
|
Academic Article
|
Drug Resistance Mutations Alter Dynamics of Inhibitor-Bound HIV-1 Protease.
|
|
Academic Article
|
Drug resistance conferred by mutations outside the active site through alterations in the dynamic and structural ensemble of HIV-1 protease.
|
|
Academic Article
|
Structural basis and distal effects of Gag substrate coevolution in drug resistance to HIV-1 protease.
|
|
Academic Article
|
A computational analysis of the structural determinants of APOBEC3's catalytic activity and vulnerability to HIV-1 Vif.
|
|
Academic Article
|
Structural analysis of asunaprevir resistance in HCV NS3/4A protease.
|
|
Academic Article
|
Improving the Resistance Profile of Hepatitis C NS3/4A Inhibitors: Dynamic Substrate Envelope Guided Design.
|
|
Academic Article
|
Development of a Novel Screening Strategy Designed to Discover a New Class of HIV Drugs.
|
|
Academic Article
|
HIV-1 Protease and Substrate Coevolution Validates the Substrate Envelope As the Substrate Recognition Pattern.
|
|
Academic Article
|
Decomposing the energetic impact of drug resistant mutations in HIV-1 protease on binding DRV.
|
|
Academic Article
|
A novel Geobacteraceae-specific outer membrane protein J (OmpJ) is essential for electron transport to Fe(III) and Mn(IV) oxides in Geobacter sulfurreducens.
|
|
Academic Article
|
Investigation of protein unfolding and stability by computer simulation.
|
|
Academic Article
|
Positive Selection Drives Preferred Segment Combinations during Influenza Virus Reassortment.
|
|
Academic Article
|
Drug-resistant HIV-1 protease regains functional dynamics through cleavage site coevolution.
|
|
Academic Article
|
The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization.
|
|
Academic Article
|
Structure-guided design of a high affinity inhibitor to human CtBP.
|
|
Academic Article
|
REdiii: a pipeline for automated structure solution.
|
|
Academic Article
|
Structure of the Vif-binding domain of the antiviral enzyme APOBEC3G.
|
|
Academic Article
|
A Direct Interaction with RNA Dramatically Enhances the Catalytic Activity of the HIV-1 Protease In Vitro.
|
|
Academic Article
|
Structural basis for mutation-induced destabilization of profilin 1 in ALS.
|
|
Academic Article
|
Simultaneously Targeting the NS3 Protease and Helicase Activities for More Effective Hepatitis C Virus Therapy.
|
|
Academic Article
|
Modulation of HIV protease flexibility by the T80N mutation.
|
|
Academic Article
|
A Balance between Inhibitor Binding and Substrate Processing Confers Influenza Drug Resistance.
|
|
Academic Article
|
Inhibition of APOBEC3G activity impedes double-stranded DNA repair.
|
|
Academic Article
|
Structural and Thermodynamic Effects of Macrocyclization in HCV NS3/4A Inhibitor MK-5172.
|
|
Academic Article
|
Improving Viral Protease Inhibitors to Counter Drug Resistance.
|
|
Academic Article
|
Molecular and Dynamic Mechanism Underlying Drug Resistance in Genotype 3 Hepatitis C NS3/4A Protease.
|
|
Academic Article
|
Dengue Protease Substrate Recognition: Binding of the Prime Side.
|
|
Academic Article
|
Efficient Computation of Small-Molecule Configurational Binding Entropy and Free Energy Changes by Ensemble Enumeration.
|
|
Academic Article
|
Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1.
|
|
Academic Article
|
Structural and molecular analysis of a protective epitope of Lyme disease antigen OspA and antibody interactions.
|
|
Academic Article
|
Molecular Basis for Differential Patterns of Drug Resistance in Influenza N1 and N2 Neuraminidase.
|
|
Academic Article
|
Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
|
|
Academic Article
|
Interdependence of Inhibitor Recognition in HIV-1 Protease.
|
|
Academic Article
|
Hepatitis C Virus NS3/4A Protease Inhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant Viral Variants.
|
|
Academic Article
|
CRISPR-Cas9-mediated saturated mutagenesis screen predicts clinical drug resistance with improved accuracy.
|
|
Academic Article
|
Elucidating the Interdependence of Drug Resistance from Combinations of Mutations.
|
|
Academic Article
|
Structural Determination of the Broadly Reactive Anti-IGHV1-69 Anti-idiotypic Antibody G6 and Its Idiotope.
|
|
Academic Article
|
Synonymous Mutations at the Beginning of the Influenza A Virus Hemagglutinin Gene Impact Experimental Fitness.
|
|
Academic Article
|
Hydration Structure and Dynamics of Inhibitor-Bound HIV-1 Protease.
|
|
Academic Article
|
Substrate sequence selectivity of APOBEC3A implicates intra-DNA interactions.
|
|
Academic Article
|
Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity.
|
|
Academic Article
|
Molecular Mechanism of Resistance in a Clinically Significant Double-Mutant Variant of HCV NS3/4A Protease.
|
|
Academic Article
|
Quinoxaline-Based Linear HCV NS3/4A Protease Inhibitors Exhibit Potent Activity against Drug Resistant Variants.
|
|
Academic Article
|
Probing Structural Changes among Analogous Inhibitor-Bound Forms of HIV-1 Protease and a Drug-Resistant Mutant in Solution by Nuclear Magnetic Resonance.
|
|
Academic Article
|
T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response.
|
|
Academic Article
|
Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.
|
|
Academic Article
|
A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B.
|
|
Academic Article
|
Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia.
|
|
Academic Article
|
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B.
|
|
Academic Article
|
A phase I trial of carboplatin and etoposide given as continuous infusions to adults with leukemia.
|
|
Academic Article
|
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.
|
|
Academic Article
|
Assembly of human C-terminal binding protein (CtBP) into tetramers.
|
|
Academic Article
|
Mavyret: A Pan-Genotypic Combination Therapy for the Treatment of Hepatitis C InfectionPublished as part of the Biochemistry series "Biochemistry to Bedside".
|
|
Academic Article
|
A call to arms: Unifying the fight against resistance.
|
|
Academic Article
|
Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B.
|
|
Academic Article
|
HIV-1 Protease Uses Bi-Specific S2/S2' Subsites to Optimize Cleavage of Two Classes of Target Sites.
|
|
Academic Article
|
Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA.
|
|
Academic Article
|
Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.
|
|
Academic Article
|
Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia.
|
|
Academic Article
|
Citrullination of NF-?B p65 promotes its nuclear localization and TLR-induced expression of IL-1? and TNFa.
|
|
Academic Article
|
Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease.
|
|
Academic Article
|
Constrained Mutational Sampling of Amino Acids in HIV-1 Protease Evolution.
|
|
Academic Article
|
Resistance outside the substrate envelope: hepatitis C NS3/4A protease inhibitors.
|
|
Academic Article
|
Correction to Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease.
|
|
Academic Article
|
APOBEC3s: DNA-editing human cytidine deaminases.
|
|
Academic Article
|
NMR and MD studies combined to elucidate inhibitor and water interactions of HIV-1 protease and their modulations with resistance mutations.
|
|
Academic Article
|
Picomolar to Micromolar: Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance.
|
|
Academic Article
|
Target-Specific Prediction of Ligand Affinity with Structure-Based Interaction Fingerprints.
|
|
Academic Article
|
HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2' Ligands To Optimize Hydrogen Bonding in the Substrate Envelope.
|
|
Academic Article
|
Molecular Determinants of Epistasis in HIV-1 Protease: Elucidating the Interdependence of L89V and L90M Mutations in Resistance.
|
|
Academic Article
|
Mechanism for APOBEC3G catalytic exclusion of RNA and non-substrate DNA.
|
|
Academic Article
|
Molecular and Structural Mechanism of Pan-Genotypic HCV NS3/4A Protease Inhibition by Glecaprevir.
|
|
Academic Article
|
Characterizing Protein-Ligand Binding Using Atomistic Simulation and Machine Learning: Application to Drug Resistance in HIV-1 Protease.
|
|
Academic Article
|
Optimizing the refinement of merohedrally twinned P61 HIV-1 protease-inhibitor cocrystal structures.
|
|
Academic Article
|
Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors.
|
|
Academic Article
|
IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunity.
|
|
Academic Article
|
Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere.
|
|
Academic Article
|
Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes.
|
|
Academic Article
|
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction.
|
|
Academic Article
|
Crystal Structure of a Soluble APOBEC3G Variant Suggests ssDNA to Bind in a Channel that Extends between the Two Domains.
|
|
Academic Article
|
Cryo-EM structure of CtBP2 confirms tetrameric architecture.
|
|
Academic Article
|
Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond.
|
|
Academic Article
|
Unique structural solution from a VH3-30 antibody targeting the hemagglutinin stem of influenza A viruses.
|
|
Academic Article
|
Interactions of APOBEC3s with DNA and RNA.
|
|
Academic Article
|
Deciphering Complex Mechanisms of Resistance and Loss of Potency through Coupled Molecular Dynamics and Machine Learning.
|
|
Academic Article
|
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188.
|
|
Academic Article
|
NAD(H) phosphates mediate tetramer assembly of human C-terminal binding protein (CtBP).
|
|
Academic Article
|
Inhibiting HTLV-1 Protease: A Viable Antiviral Target.
|
|
Academic Article
|
Introduction: Drug Resistance.
|
|
Academic Article
|
Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies.
|
|
Academic Article
|
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit.
|
|
Academic Article
|
Deciphering Antifungal Drug Resistance in Pneumocystis jirovecii DHFR with Molecular Dynamics and Machine Learning.
|
|
Academic Article
|
Structural basis of substrate specificity in human cytidine deaminase family APOBEC3s.
|
|
Academic Article
|
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations.
|
|
Academic Article
|
Discovery of Quinoxaline-Based P1-P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants.
|
|
Academic Article
|
Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode.
|
|
Academic Article
|
Viral proteases: Structure, mechanism and inhibition.
|
|
Concept
|
Atazanavir Sulfate
|
|
Concept
|
Silent Mutation
|
|
Concept
|
High-Throughput Nucleotide Sequencing
|
|
Concept
|
Single-Domain Antibodies
|
|
Concept
|
Molecular Docking Simulation
|
|
Concept
|
Influenza A Virus, H7N9 Subtype
|
|
Concept
|
Endoplasmic Reticulum Stress
|
|
Concept
|
Chemistry Techniques, Synthetic
|
|
Concept
|
Sialic Acid Binding Ig-like Lectin 3
|
|
Concept
|
Clustered Regularly Interspaced Short Palindromic Repeats
|
|
Concept
|
CRISPR-Cas Systems
|
|
Concept
|
Spike Glycoprotein, Coronavirus
|
|
Academic Article
|
Identification of a Permissive Secondary Mutation That Restores the Enzymatic Activity of Oseltamivir Resistance Mutation H275Y.
|
|
Academic Article
|
Deciphering the Molecular Mechanism of HCV Protease Inhibitor Fluorination as a General Approach to Avoid Drug Resistance.
|
|
Academic Article
|
Call for Papers: Drug Resistance in Infectious Diseases and Beyond.
|
|
Academic Article
|
Quantitative structural analysis of influenza virus by cryo-electron tomography and convolutional neural networks.
|
|
Academic Article
|
Analyses of HIV proteases variants at the threshold of viability reveals relationships between processing efficiency and fitness.
|
|
Academic Article
|
HIV-1 VIF and human APOBEC3G interaction directly observed through molecular specific labeling using a new dual promotor vector.
|
|
Academic Article
|
Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms.
|
|
Academic Article
|
Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance.
|
|
Academic Article
|
Dual Inhibitors of Main Protease (MPro) and Cathepsin L as Potent Antivirals against SARS-CoV2.
|
|
Academic Article
|
Structure of the catalytically active APOBEC3G bound to a DNA oligonucleotide inhibitor reveals tetrahedral geometry of the transition state.
|
|
Academic Article
|
Allosteric quinoxaline-based inhibitors of the flavivirus NS2B/NS3 protease.
|
|
Academic Article
|
Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants.
|
|
Academic Article
|
Non-canonical pattern recognition of a pathogen-derived metabolite by a nuclear hormone receptor identifies virulent bacteria in C.?elegans.
|
|
Academic Article
|
Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance.
|
|
Academic Article
|
Crystal Structures of Inhibitor-Bound Main Protease from Delta- and Gamma-Coronaviruses.
|
|
Academic Article
|
FruitFire: a luciferase based on a fruit fly metabolic enzyme.
|
|
Academic Article
|
HIV-1 protease inhibitors with a P1 phosphonate modification maintain potency against drug-resistant variants by increased interactions with flap residues.
|
|
Academic Article
|
Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main Protease.
|
|
Academic Article
|
Addressing the dNTP bottleneck restricting prime editing activity.
|
|
Academic Article
|
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.
|
|
Academic Article
|
Chronic lymphocytic leukemia: recommendations.
|
|
Academic Article
|
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.
|
|
Academic Article
|
Report of an international working group to standardize response criteria for myelodysplastic syndromes.
|
|
Academic Article
|
Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group.
|
|
Academic Article
|
Direct delivery of stabilized Cas-embedded base editors achieves efficient and accurate editing of clinically relevant targets.
|
|
Academic Article
|
Contributions of Hyperactive Mutations in Mpro from SARS-CoV-2 to Drug Resistance.
|
|
Academic Article
|
Myelodysplastic syndromes standardized response criteria: further definition.
|
|
Academic Article
|
Increasing intracellular dNTP levels improves prime editing efficiency.
|
|
Academic Article
|
FcRn-enhancing mutations lead to increased and prolonged levels of the HIV CCR5-blocking monoclonal antibody leronlimab in the fetuses and newborns of pregnant rhesus macaques.
|
|
Academic Article
|
Elucidating the Substrate Envelope of Enterovirus 68-3C Protease: Structural Basis of Specificity and Potential Resistance.
|
|
Academic Article
|
Next generation APOBEC3 inhibitors: Optimally designed for potency and nuclease stability.
|
|
Academic Article
|
Virion-associated influenza hemagglutinin clusters upon sialic acid binding visualized by cryo-electron tomography.
|
|
Academic Article
|
Efficient convergent synthesis of 1,3-diazepinone nucleosides by ring-closing metathesis and direct glycosylation.
|
|
Academic Article
|
Direct delivery of Cas-embedded cytosine base editors as ribonucleoprotein complexes for efficient and accurate editing of clinically relevant targets.
|
|
Academic Article
|
Structural Analysis of Inhibitor Binding to Enterovirus-D68 3C Protease.
|
|
Academic Article
|
Next generation?APOBEC3 inhibitors: optimally designed for potency and nuclease stability.
|
|
Academic Article
|
Virion-associated influenza hemagglutinin clusters upon sialic acid binding visualized by cryoelectron tomography.
|
|
Academic Article
|
Molecular mechanisms of drug resistance and compensation in SARS-CoV-2 main protease: the interplay between E166 and L50.
|